SCHEMBL6998902

SCHEMBL6998902

CCOC(=O)c1cc(C)c(CC[C@@H](O)CNC(=O)OC(C)(C)C)s1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SERPINE1 P05121 1/20 0.38
SYK P43405 1/20 0.36
HDAC3 O15379 2/20 0.36
HDAC4 P56524 1/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
HTT P42858 2/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
ABCB1 P08183 1/20 0.34
AAK1 Q2M2I8 1/20 0.33
MAPT P10636 3/20 0.33
KDM4E B2RXH2 3/20 0.33
TDP1 Q9NUW8 2/20 0.33
NPSR1 Q6W5P4 1/20 0.33
USP10 Q14694 1/20 0.32
DHODH Q02127 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP2C9 P11712 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7000933 1.00 SERPINE1 (0.38) SERPINE1SYKHDAC3HDAC4HDAC1
SCHEMBL6998895 1.00 SERPINE1 (0.38) SERPINE1SYKHDAC3HDAC4HDAC1
SCHEMBL8685895 0.88 SERPINE1 (0.38) SERPINE1SYKHDAC3HDAC4HDAC1
SCHEMBL8685891 0.88 SERPINE1 (0.38) SERPINE1SYKHDAC3HDAC4HDAC1
SCHEMBL7001569 0.85 SERPINE1 (0.37) SERPINE1SYKHDAC3HDAC4HDAC1
SCHEMBL7001565 0.85 SERPINE1 (0.37) SERPINE1SYKHDAC3HDAC4HDAC1
SCHEMBL8362207 0.85 SERPINE1 (0.37) SERPINE1SYKHDAC3HDAC4HDAC1
SCHEMBL6998667 0.84 SERPINE1 (0.39) SERPINE1SYKHDAC3HDAC4HDAC1
SCHEMBL6998671 0.84 SERPINE1 (0.39) SERPINE1SYKHDAC3HDAC4HDAC1
SCHEMBL7092531 0.84 SERPINE1 (0.37) SERPINE1SYKHDAC3HDAC4HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0846111-B1 SYNTHESES OF OPTICALLY PURE COMPOUNDS USEFUL AS GARFT INHIBITORS AND THEIR INTERMEDIATES AGOURON PHARMA (US) 2003-08-27 EP disclosed
US-5981748-A Synthesis of optically pure compounds useful as GARFT inhibitors and their intermediates AGOURON PHARMACEUTICALS, INC. (US) 1999-11-09 US disclosed
EP-0846111-A1 SYNTHESES OF OPTICALLY PURE COMPOUNDS USEFUL AS GARFT INHIBITORS AND THEIR INTERMEDIATES AGOURON PHARMACEUTICALS, INC. (US) 1998-06-10 EP disclosed
WO-1996040674-A1 SYNTHESES OF OPTICALLY PURE COMPOUNDS USEFUL AS GARFT INHIBITORS AND THEIR INTERMEDIATES AGOURON PHARMACEUTICALS, INC. (US) 1996-12-19 WO disclosed